Amedeo Smart

Free Medical Literature Service




  Free Subscription

Articles published in
    July 2021
  1. CHEN J, Zhang Q, Liu D, Liu Z, et al
    Exosomes: advances, development and potential therapeutic strategies in diabetic nephropathy.
    Metabolism. 2021 Jul 1:154834. doi: 10.1016/j.metabol.2021.154834.
    >> Share

    June 2021
  2. PRANATA R, Henrina J, Raffaello WM, Lawrensia S, et al
    Diabetes and COVID-19: The Past, The Present, and The Future.
    Metabolism. 2021 Jun 10:154814. doi: 10.1016/j.metabol.2021.154814.
    >> Share

  3. LORETELLI C, Rocchio F, D'Addio F, Nasr MB, et al
    The IL-8-CXCR1/2 axis contributes to diabetic kidney disease.
    Metabolism. 2021 Jun 4:154804. doi: 10.1016/j.metabol.2021.154804.
    >> Share

  4. DING Y, Li G, Zhou Z, Deng T, et al
    Molecular mechanisms underlying hepatitis C virus infection-related diabetes.
    Metabolism. 2021 Jun 3:154802. doi: 10.1016/j.metabol.2021.154802.
    >> Share

  5. TESSIER CM, Kokkinos A, Mingrone G, Koliaki C, et al
    COVID-19 editorial: mechanistic links and therapeutic challenges for metabolic diseases one year into the COVID-19 pandemic.
    Metabolism. 2021;119:154769.
    >> Share

  6. MUZUROVIC E, Mikhailidis DP, Mantzoros C
    Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.
    Metabolism. 2021;119:154770.
    >> Share

  7. LAMPRINOU A, Willmann C, Machann J, Schick F, et al
    Determinants of hepatic insulin clearance - Results from a Mendelian Randomization study.
    Metabolism. 2021;119:154776.
    >> Share

    May 2021
  8. PRATTICHIZZO F, de Candia P, Ceriello A
    Diabetes and kidney disease: emphasis on treatment with SGLT-2 inhibitors and GLP-1 receptor agonists.
    Metabolism. 2021 May 21:154799. doi: 10.1016/j.metabol.2021.154799.
    >> Share

  9. JANSSEN AWM, Stienstra R, Jaeger M, van Gool AJ, et al
    Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetes.
    Metabolism. 2021 May 7:154795. doi: 10.1016/j.metabol.2021.154795.
    >> Share

  10. CATALDO LR, Vishnu N, Singh T, Bertonnier-Brouty L, et al
    The MafA-target gene PPP1R1A regulates GLP1R-mediated amplification of glucose-stimulated insulin secretion in beta-cells.
    Metabolism. 2021;118:154734.
    >> Share

  11. SALGADO JV, Goes MA, Salgado Filho N
    FGF21 and Chronic Kidney Disease.
    Metabolism. 2021;118:154738.
    >> Share

    April 2021
    Diabetes in Pregnancy 100 Years after the Discovery of Insulin: Hot Topics and Open Questions to be Addressed in the Coming Years.
    Metabolism. 2021 Apr 7:154772. doi: 10.1016/j.metabol.2021.154772.
    >> Share

  13. ZHAO T, Wang J, Chen Y, Wang S, et al
    Antiallergic drug Mebhydrolin ameliorates glucose homeostasis in type 2 diabetic mice by functioning as a selective FXR antagonist.
    Metabolism. 2021 Apr 5:154771. doi: 10.1016/j.metabol.2021.154771.
    >> Share

  14. HUERTA GUEVARA AP, McGowan SJ, Kazantzis M, Stallons TR, et al
    Increased insulin sensitivity and diminished pancreatic beta-cell function in DNA repair deficient Ercc1(d/-) mice.
    Metabolism. 2021;117:154711.
    >> Share

  15. LIU Z, Zhu H, Ma Y, Tang Z, et al
    AGEs exacerbates coronary microvascular dysfunction in NoCAD by activating endoplasmic reticulum stress-mediated PERK signaling pathway.
    Metabolism. 2021;117:154710.
    >> Share

  16. TOBIAS DK, Mora S, Verma S, Billia F, et al
    Fasting status and metabolic health in relation to plasma branched chain amino acid concentrations in women.
    Metabolism. 2021;117:154391.
    >> Share

    March 2021
  17. XU X, Dong Y, Ma N, Kong W, et al
    MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice.
    Metabolism. 2021 Mar 25:154768. doi: 10.1016/j.metabol.2021.154768.
    >> Share

  18. CIARDULLO S, Perseghin G
    Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes.
    Metabolism. 2021 Mar 11:154752. doi: 10.1016/j.metabol.2021.154752.
    >> Share

  19. WU M, Yang Z, Zhang C, Shi Y, et al
    Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Metabolism. 2021 Mar 3:154748. doi: 10.1016/j.metabol.2021.154748.
    >> Share

  20. STEVANOVIC-SILVA J, Beleza J, Coxito P, Pereira S, et al
    Maternal high-fat high-sucrose diet and gestational exercise modulate hepatic fat accumulation and liver mitochondrial respiratory capacity in mothers and male offspring.
    Metabolism. 2021;116:154704.
    >> Share

  21. LI X, Jiang Y, Sun X, Wu Y, et al
    METTL3 is required for maintaining beta-cell function.
    Metabolism. 2021;116:154702.
    >> Share

  22. AHN J, Koh J, Kim D, Kim G, et al
    Mean and visit-to-visit variability of glycemia and left ventricular diastolic dysfunction: A longitudinal analysis of 3025 adults with serial echocardiography.
    Metabolism. 2021;116:154451.
    >> Share

    February 2021
  23. WANG H, Huang X, Xu P, Liu X, et al
    Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-kappaB pathway.
    Metabolism. 2021 Feb 24:154740. doi: 10.1016/j.metabol.2021.154740.
    >> Share

  24. POLYZOS SA, Mantzoros CS
    Diabetes mellitus: 100 years since the discovery of insulin.
    Metabolism. 2021 Feb 18:154737. doi: 10.1016/j.metabol.2021.154737.
    >> Share

  25. KARLSSON HKR, Kasahara A, Ikeda M, Chibalin A, et al
    Quantitative Phosphoproteomic Analysis of IRS1 in Skeletal Muscle from Men with Normal Glucose Tolerance or Type 2 Diabetes: A Case-Control Study.
    Metabolism. 2021 Feb 10:154726. doi: 10.1016/j.metabol.2021.154726.
    >> Share

  26. AHN M, Oh E, McCown EM, Wang X, et al
    A requirement for PAK1 to support mitochondrial function and maintain cellular redox balance via electron transport chain proteins to prevent beta-cell apoptosis.
    Metabolism. 2021;115:154431.
    >> Share

    January 2021
  27. YANG G, Wei J, Liu P, Zhang Q, et al
    Role of the gut microbiota in type 2 diabetes and related diseases.
    Metabolism. 2021 Jan 23:154712. doi: 10.1016/j.metabol.2021.154712.
    >> Share

  28. ANGELIDI AM, Kokkinos A, Katechaki E, Ros E, et al
    Mediterranean diet as a nutritional approach for COVID-19.
    Metabolism. 2021;114:154407.
    >> Share

  29. CINTI F, Mezza T, Severi I, Suleiman M, et al
    Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans.
    Metabolism. 2021;114:154414.
    >> Share

  30. WANG X, Chen S, He J, Chen W, et al
    Histone methyltransferases G9a mediated lipid-induced M1 macrophage polarization through negatively regulating CD36.
    Metabolism. 2021;114:154404.
    >> Share

    December 2020
  31. SOTOMAYOR CG, Oskooei SS, Bustos NI, Nolte IM, et al
    Serum Uric Acid is Associated with Increased Risk of Posttransplantation Diabetes in Kidney Transplant Recipients: A Prospective Cohort Study.
    Metabolism. 2020 Dec 11:154465. doi: 10.1016/j.metabol.2020.154465.
    >> Share

    November 2020
  32. BLOMDAHL J, Nasr P, Ekstedt M, Kechagias S, et al
    Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus.
    Metabolism. 2020 Nov 24:154439. doi: 10.1016/j.metabol.2020.154439.
    >> Share

  33. JI D, Zhang M, Qin E, Zhang L, et al
    Obesity, Diabetes, Non-alcoholic Fatty Liver Disease and Metabolic Dysfunction Associated Fatty Liver Disease are Proinflammatory Hypercoagulable States associated with Severe Disease and Thrombosis in Covid-19.
    Metabolism. 2020 Nov 18:154437. doi: 10.1016/j.metabol.2020.154437.
    >> Share

  34. QU J, Qu HQ, Bradfield J, Glessner J, et al
    Association of DLL1 with type 1 diabetes in patients characterized by low polygenic risk score.
    Metabolism. 2020 Nov 3:154418. doi: 10.1016/j.metabol.2020.154418.
    >> Share

  35. MOIN ASM, Al-Qaissi A, Sathyapalan T, Atkin SL, et al
    Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: biomarker response to hypoglycemia.
    Metabolism. 2020 Nov 3:154417. doi: 10.1016/j.metabol.2020.154417.
    >> Share

    October 2020
  36. GRESPAN E, Giorgino T, Natali A, Ferrannini E, et al
    Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes.
    Metabolism. 2020 Oct 30:154415. doi: 10.1016/j.metabol.2020.154415.
    >> Share

  37. FIORENTINO TV, Monroy A, Kamath S, Sotero R, et al
    Pioglitazone corrects dysregulation of skeletal muscle mitochondrial proteins involved in ATP synthesis in type 2 diabetes.
    Metabolism. 2020 Oct 30:154416. doi: 10.1016/j.metabol.2020.154416.
    >> Share

  38. QIU D, Nikita D, Zhang L, Deng J, et al
    ICAM-1 deletion delays the repair process in aging diabetic mice.
    Metabolism. 2020;114:154412.
    >> Share

  39. OTOMO H, Nara M, Kato S, Shimizu T, et al
    Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy.
    Metabolism. 2020 Oct 15:154405. doi: 10.1016/j.metabol.2020.154405.
    >> Share

  40. SHIN SJ, Chen CH, Kuo WC, Chan HC, et al
    Disruption of retinoid homeostasis induces RBP4 overproduction in diabetes: O-GlcNAcylation involved.
    Metabolism. 2020;113:154403.
    >> Share

  41. ATANES P, Lee V, Huang GC, Persaud SJ, et al
    The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes.
    Metabolism. 2020 Oct 12:154394. doi: 10.1016/j.metabol.2020.154394.
    >> Share

  42. LI Y, Li J, Zhao C, Yang L, et al
    Hyperglycemia-reduced NAD(+) biosynthesis impairs corneal epithelial wound healing in diabetic mice.
    Metabolism. 2020 Oct 11:154402. doi: 10.1016/j.metabol.2020.154402.
    >> Share

  43. MISHRA RC, Kyle BD, Kendrick DJ, Svystonyuk D, et al
    KCa channel activation normalizes endothelial function in Type 2 Diabetic resistance arteries by improving intracellular Ca(2+) mobilization.
    Metabolism. 2020 Oct 8:154390. doi: 10.1016/j.metabol.2020.154390.
    >> Share

  44. MANTOVANI A, Scorletti E, Mosca A, Alisi A, et al
    Complications, morbidity and mortality of nonalcoholic fatty liver disease.
    Metabolism. 2020;111S:154170.
    >> Share

    September 2020
  45. MOIN ASM, Sathyapalan T, Atkin SL, Butler AE, et al
    M2 macrophage markers in type 2 diabetes.
    Metabolism. 2020 Sep 16:154374. doi: 10.1016/j.metabol.2020.154374.
    >> Share

  46. SONG D, Yang Q, Jiang X, Shan A, et al
    YY1 deficiency in beta-cells leads to mitochondrial dysfunction and diabetes in mice.
    Metabolism. 2020 Sep 8:154353. doi: 10.1016/j.metabol.2020.154353.
    >> Share

  47. PRATTICHIZZO F, de Candia P, De Nigris V, Nicolucci A, et al
    Legacy effect of intensive glucose control on major adverse cardiovascular outcome: Systematic review and meta-analyses of trials according to different scenarios.
    Metabolism. 2020;110:154308.
    >> Share

  48. STEFANOVSKI D, Vellanki P, Smiley-Byrd DD, Umpierrez GE, et al
    Population insulin sensitivity from sparsely sampled oral glucose tolerance tests.
    Metabolism. 2020;110:154298.
    >> Share

  49. PANAGIOTAKOU A, Yavropoulou M, Nasiri-Ansari N, Makras P, et al
    Extra-skeletal effects of bisphosphonates.
    Metabolism. 2020;110:154264.
    >> Share

    August 2020
  50. HAMER M, Gale CR, Batty GD
    Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: population-based, prospective cohort study.
    Metabolism. 2020 Aug 21:154344. doi: 10.1016/j.metabol.2020.154344.
    >> Share

  51. SUN Y, Zhou S, Shi Y, Zhou Y, et al
    Inhibition of miR-153, an IL-1beta-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes.
    Metabolism. 2020 Aug 11:154335. doi: 10.1016/j.metabol.2020.154335.
    >> Share

  52. WILSON C, Zhang X, Lee MD, MacDonald M, et al
    Disrupted Endothelial Cell Heterogeneity and Network Organization Impair Vascular Function in Prediabetic Obesity.
    Metabolism. 2020 Aug 10:154340. doi: 10.1016/j.metabol.2020.154340.
    >> Share

  53. LIU X, Xu C, Xu L, Li X, et al
    Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway.
    Metabolism. 2020;111:154334.
    >> Share

  54. LOKAU J, Waetzig GH, Rose-John S, Garbers C, et al
    Letter to the Editor: Non-specific effects resulting from use of tocilizumab in mice.
    Metabolism. 2020;109:154281.
    >> Share

  55. ZHOU JB, Tang X, Han M, Yang J, et al
    Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis.
    Metabolism. 2020;109:154265.
    >> Share

  56. JAMES D, Umekwe N, Edeoga C, Nyenwe E, et al
    Multi-year reproducibility of hyperinsulinemic euglycemic clamp-derived insulin sensitivity in free-living adults: Association with incident prediabetes in the POP-ABC study.
    Metabolism. 2020;109:154263.
    >> Share

    July 2020
  57. WEI R, Cui X, Feng J, Gu L, et al
    Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
    Metabolism. 2020 Jul 23:154324. doi: 10.1016/j.metabol.2020.154324.
    >> Share

  58. KONG W, Zhang J, Xu Y, Li L, et al
    Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection.
    Metabolism. 2020;108:154255.
    >> Share

    June 2020
  59. MARRANO N, Biondi G, Cignarelli A, Perrini S, et al
    Functional loss of pancreatic islets in type 2 diabetes: how can we halt it?
    Metabolism. 2020 Jun 26:154304. doi: 10.1016/j.metabol.2020.154304.
    >> Share

  60. CHAMORRO-PAREJA N, Parthasarathy S, Annam J, Hoffman J, et al
    Unexpected high mortality in COVID-19 and diabetic ketoacidosis.
    Metabolism. 2020 Jun 23:154301. doi: 10.1016/j.metabol.2020.154301.
    >> Share

  61. DEWIDAR B, Kahl S, Pafili K, Roden M, et al
    Metabolic liver disease in diabetes - from mechanisms to clinical trials.
    Metabolism. 2020 Jun 19:154299. doi: 10.1016/j.metabol.2020.154299.
    >> Share

  62. STOIAN AP, Sachinidis A, Stoica RA, Nikolic D, et al
    The efficacy and safety of Dipeptyl Peptidase-4 inhibitors compared to other Oral glucose-lowering medications in the treatment of type 2 diabetes.
    Metabolism. 2020 Jun 15:154295. doi: 10.1016/j.metabol.2020.154295.
    >> Share

  63. DAVIES MJ, Bianchi C, Del Prato S
    Use of incretin-based medications: what do current international recommendations suggest with respect to GLP-1 receptor agonists and DPP-4 inhibitors?
    Metabolism. 2020;107:154242.
    >> Share

    May 2020
  64. YANG T, Heng C, Zhou Y, Hu Y, et al
    Targeting mammalian serine/threonine-protein kinase 4 through yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
    Metabolism. 2020 May 3:154258. doi: 10.1016/j.metabol.2020.154258.
    >> Share

  65. MORIERI ML, Rigato M, Frison V, Simioni N, et al
    Effectiveness of dulaglutide vs liraglutide and exenatide once-weekly. A real-world study and meta-analysis of observational studies.
    Metabolism. 2020;106:154190.
    >> Share

    April 2020
  66. MEANS C
    Mechanisms of increased morbidity and mortality of SARS-CoV-2 infection in individuals with diabetes: what this means for an effective management strategy.
    Metabolism. 2020 Apr 28:154254. doi: 10.1016/j.metabol.2020.154254.
    >> Share

  67. MUKHTAZR S, Mukhtar S
    Mental Health and Psychological Distress in People with Diabetes during COVID-19.
    Metabolism. 2020 Apr 23:154248. doi: 10.1016/j.metabol.2020.154248.
    >> Share

  68. ANGELIDI AM, Belanger MJ, Mantzoros CS
    COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next.
    Metabolism. 2020 Apr 19:154245. doi: 10.1016/j.metabol.2020.154245.
    >> Share

  69. GUO D, Mizukami H, Osonoi S, Takahashi K, et al
    Beneficial effects of combination therapy of canagliflozin and teneligliptin on diabetic polyneuropathy and beta-cell volume density in spontaneously type 2 diabetic Goto-Kakizaki rats.
    Metabolism. 2020 Apr 14:154232. doi: 10.1016/j.metabol.2020.154232.
    >> Share

  70. KLONOFF DC, Umpierrez GE
    COVID-19 in patients with diabetes: risk factors that increase morbidity.
    Metabolism. 2020 Apr 7:154224. doi: 10.1016/j.metabol.2020.154224.
    >> Share

  71. MENGOZZI A, Trico D, Nesti L, Petrie J, et al
    Disruption of fasting and post-load glucose homeostasis are largely independent and sustained by distinct and early major beta-cell function defects: a cross-sectional and longitudinal analysis of the Relationship between Insulin Sensitivity and Cardi
    Metabolism. 2020;105:154185.
    >> Share

    March 2020
  72. VAN CAMPENHOUT S, Tilleman L, Lefere S, Vandierendonck A, et al
    Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
    Metabolism. 2020 Mar 31:154220. doi: 10.1016/j.metabol.2020.154220.
    >> Share

  73. GAR C, Rottenkolber M, Haenelt M, Potzel AL, et al
    Altered metabolic and hormonal responses to moderate exercise in overweight/obesity.
    Metabolism. 2020 Mar 30:154219. doi: 10.1016/j.metabol.2020.154219.
    >> Share

  74. KATSIKI N, Ferrannini E, Mantzoros C
    New American Diabetes Association (ADA)/European Association for the Study of diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: placing them into a practicing physician's perspective.
    Metabolism. 2020 Mar 25:154218. doi: 10.1016/j.metabol.2020.154218.
    >> Share

  75. ZHOU J, Tan J
    Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.
    Metabolism. 2020;107:154216.
    >> Share

  76. HILL MA, Mantzoros C, Sowers JR
    Commentary: COVID-19 in Patients with Diabetes.
    Metabolism. 2020 Mar 24:154217. doi: 10.1016/j.metabol.2020.154217.
    >> Share

    February 2020
  77. MCCULLOCH LJ, Bramwell LR, Knight B, Kos K, et al
    Circulating and tissue specific transcription of angiopoietin-like protein 4 in human Type 2 diabetes.
    Metabolism. 2020 Feb 26:154192. doi: 10.1016/j.metabol.2020.154192.
    >> Share

  78. WEI X, Wei X, Lu Z, Li L, et al
    Activation of TRPV1 channel antagonizes diabetic nephropathy through inhibiting endoplasmic reticulum-mitochondria contact in podocytes.
    Metabolism. 2020 Feb 12:154182. doi: 10.1016/j.metabol.2020.154182.
    >> Share

  79. ADAMS JD, Man CD, Laurenti MC, Andrade MDH, et al
    Fasting glucagon concentrations are associated with longitudinal decline of beta-cell function in non-diabetic humans.
    Metabolism. 2020 Feb 8:154175. doi: 10.1016/j.metabol.2020.154175.
    >> Share

    January 2020
  80. WANG P, Yang X, Zhang Z, Song J, et al
    Corrigendum to "Depletion of NAD pool contributes to impairment of endothelial progenitor cell mobilization in diabetes" [Metab Clin Exp 65 (2016) 852-862].
    Metabolism. 2020;104:154139.
    >> Share

  81. HSU YH, Chen YC, Chen YW, Chiu TH, et al
    Far-infrared radiation prevents decline in beta-cell mass and function in diabetic mice via the mitochondria-mediated Sirtuin1 pathway.
    Metabolism. 2020 Jan 9:154143. doi: 10.1016/j.metabol.2020.154143.
    >> Share

  82. VUILLEUMIER NC, Gauthier BR
    Time for a paradigm shift in treating type 1 diabetes mellitus: coupling inflammation to islet Regeneration.
    Metabolism. 2020 Jan 2:154137. doi: 10.1016/j.metabol.2020.154137.
    >> Share

    December 2019
  83. GUARDADO-MENDOZA R, Salazar-Lopez SS, de la Luz Alvarez-Canales MF, Vazquez DF, et al
    The combination of Linagliptin, Metformin and Lifestyle Modification to prevent Type 2 Diabetes (PRELLIM). A randomized clinical trial.
    Metabolism. 2019 Dec 27:154054. doi: 10.1016/j.metabol.2019.154054.
    >> Share

  84. RANJBAR G, Mikhailidis DP, Sahebkar A
    Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!
    Metabolism. 2019;101:154001.
    >> Share

  85. KITAZAWA M, Fujihara K, Osawa T, Yamamoto M, et al
    Risk of coronary artery disease according to glucose abnormality status and prior coronary artery disease in Japanese men.
    Metabolism. 2019;101:153991.
    >> Share

    November 2019
  86. CHAVEZ-TALAVERA O, Wargny M, Pichelin M, Descat A, et al
    Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetes.
    Metabolism. 2019 Nov 27:154042. doi: 10.1016/j.metabol.2019.154042.
    >> Share

  87. NAUCK MA
    The rollercoaster history of using physiological and pharmacological properties of incretin hormones to develop diabetes medications with a convincing benefit-risk relationship.
    Metabolism. 2019 Nov 27:154031. doi: 10.1016/j.metabol.2019.154031.
    >> Share

  88. XU BH, Sheng J, You YK, Huang XR, et al
    Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy.
    Metabolism. 2019 Nov 14:154013. doi: 10.1016/j.metabol.2019.154013.
    >> Share

  89. SUN Y, Zhou S, Guo H, Zhang J, et al
    Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
    Metabolism. 2019 Nov 7:154002. doi: 10.1016/j.metabol.2019.154002.
    >> Share

  90. TREMBLAY J, Hamet P
    Environmental and genetic contributions to diabetes.
    Metabolism. 2019;100S:153952.
    >> Share

    October 2019
  91. FUKUHARA S, Yasukawa K, Sato M, Ikeda H, et al
    Clinical usefulness of human serum nonmercaptalbumin to mercaptalbumin ratio as a biomarker for diabetic complications and disability in activities of daily living in elderly patients with diabetes.
    Metabolism. 2019 Oct 28:153995. doi: 10.1016/j.metabol.2019.153995.
    >> Share

  92. FARNGREN J, Ahren B
    Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes.
    Metabolism. 2019;99:25-31.
    >> Share

    August 2019
  93. SUN Y, Gao Y, Chen J, Sun H, et al
    Evidence mapping of recommendations on diagnosis and therapeutic strategies for diabetes foot: an international review of 22 guidelines.
    Metabolism. 2019 Aug 5:153956. doi: 10.1016/j.metabol.2019.153956.
    >> Share

    July 2019
  94. JIANG Z, Zhou J, Li T, Tian M, et al
    Hepatic deficiency of Poldip2 in type 2 diabetes dampens lipid and glucose homeostasis.
    Metabolism. 2019 Jul 25:153948. doi: 10.1016/j.metabol.2019.153948.
    >> Share

  95. HUANG S, Ma S, Ning M, Yang W, et al
    TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
    Metabolism. 2019 Jul 8. pii: S0026-0495(19)30136.
    >> Share

    June 2019
    Initial injectable therapy in type 2 diabetes: key considerations when choosing between glucagon-like peptide 1 receptor agonists and insulin.
    Metabolism. 2019 Jun 27. pii: S0026-0495(19)30127.
    >> Share

    May 2019
  97. QUICLET C, Dittberner N, Gassler A, Stadion M, et al
    Pancreatic adipocytes mediate hypersecretion of insulin in diabetes-susceptible mice.
    Metabolism. 2019 May 17. pii: S0026-0495(19)30093.
    >> Share

    April 2019
  98. YANG T, Shu F, Yang H, Heng C, et al
    YY1:a novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis.
    Metabolism. 2019 Apr 25. pii: S0026-0495(19)30085.
    >> Share

  99. ZENG Y, Mtintsilana A, Goedecke JH, Micklesfield LK, et al
    Alterations in the metabolism of phospholipids, bile acids and branched-chain amino acids predicts development of type 2 diabetes in black south African women: a prospective cohort study.
    Metabolism. 2019 Apr 4. pii: S0026-0495(19)30067.
    >> Share

  100. VAN NIEROP FS, de Jonge C, Kulik W, Bouvy N, et al
    Duodenal-jejunal lining increases postprandial unconjugated bile acid responses and disrupts the bile acid-FXR-FGF19 axis in humans.
    Metabolism. 2019;93:25-32.
    >> Share

    March 2019
  101. GILARDI F, Winkler C, Quignodon L, Diserens JG, et al
    Systemic PPARgamma deletion in mice provokes lipoatrophy, organomegaly, severe type 2 diabetes and metabolic inflexibility.
    Metabolism. 2019 Mar 13. pii: S0026-0495(19)30051.
    >> Share

  102. KOOPMAN ADM, Beulens JW, Voerman E, Rauh SP, et al
    GAD65 antibodies and incident type 2 Diabetes mellitus.
    Metabolism. 2019 Mar 7. pii: S0026-0495(19)30049.
    >> Share

    February 2019
  103. PERADZE N, Farr OM, Mantzoros CS
    Research developments in metabolism 2018.
    Metabolism. 2019;91:70-79.
    >> Share

    January 2019
  104. ZHOU Z, Sun B, Huang S, Jia W, et al
    The tRNA-associated dysregulation in diabetes mellitus.
    Metabolism. 2019 Jan 31. pii: S0026-0495(19)30032.
    >> Share

  105. KIM MJ, Kim MN, Min SH, Ham DS, et al
    Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes.
    Metabolism. 2019 Jan 4. pii: S0026-0495(18)30267.
    >> Share

  106. AHMAD A, Ali T, Kim MW, Khan A, et al
    Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARalpha signaling in ob/ob and db/db transgenic mouse models.
    Metabolism. 2019;90:31-43.
    >> Share

    December 2018
  107. SHAH M, Laurenti MC, Man CD, Ma J, et al
    Contribution of endogenous glucagon-like Peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after roux-en-Y gastric bypass (RYGB).
    Metabolism. 2018 Dec 23. pii: S0026-0495(18)30265.
    >> Share

    November 2018
  108. LAYTON J, Powe C, Allard C, Battista MC, et al
    Maternal lipid profile differs by gestational diabetes physiologic subtype.
    Metabolism. 2018 Nov 20. pii: S0026-0495(18)30247.
    >> Share

  109. SUAREZ AL
    Burden of cancer attributable to obesity, type 2 diabetes and associated risk factors.
    Metabolism. 2018 Nov 6. pii: S0026-0495(18)30231.
    >> Share

    October 2018
  110. PATH G, Perakakis N, Mantzoros CS, Seufert J, et al
    Stem cells in the treatment of diabetes mellitus - focus on mesenchymal stem cells.
    Metabolism. 2018 Oct 17. pii: S0026-0495(18)30215.
    >> Share

  111. YARIBEYGI H, Katsiki N, Behnam B, Iranpanah H, et al
    MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment.
    Metabolism. 2018;87:48-55.
    >> Share

    May 2018
  112. TSENG CH
    Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus.
    Metabolism. 2018 May 2. pii: S0026-0495(18)30115.
    >> Share

  113. YANG P, Huang T, Xu G
    Corrigendum to "The novel mineralocorticoid receptor antagonist finerenone in diabetic kidney disease: Progress and challenges" [Metabolism 65 (2016) 1342-1349].
    Metabolism. 2018;82:124.
    >> Share

    April 2018
  114. KINTIRAKI E, Goulis DG
    Gestational Diabetes Mellitus: multi-disciplinary treatment approaches.
    Metabolism. 2018 Apr 5. pii: S0026-0495(18)30097.
    >> Share

    March 2018
  115. DOKE T, Ishimoto T, Hayasaki T, Ikeda S, et al
    Lacking Ketohexokinase-A Exacerbates Renal Injury in Streptozotocin-induced Diabetic Mice.
    Metabolism. 2018 Mar 28. pii: S0026-0495(18)30092.
    >> Share

  116. BASOLO A, Burkholder J, Osgood K, Graham A, et al
    Exenatide has a Pronounced Effect on Energy Intake but not Energy Expenditure in Non-Diabetic Subjects with Obesity: A Randomized, Double-blind, Placebo-Controlled Trial.
    Metabolism. 2018 Mar 26. pii: S0026-0495(18)30089.
    >> Share

  117. ZHENG T, Liu H, Qin L, Chen B, et al
    Oxidative Stress-Mediated Influence of Plasma DPP4 Activity to BDNF Ratio on Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients: Results From the GDMD Study in China.
    Metabolism. 2018 Mar 20. pii: S0026-0495(18)30086.
    >> Share

  118. QIU T, Li M, Tanner MA, Yang Y, et al
    Depletion of dendritic cells in perivascular adipose tissue improves arterial relaxation responses in type 2 diabetic mice.
    Metabolism. 2018 Mar 9. pii: S0026-0495(18)30068.
    >> Share

  119. CHO YY, Cho SI
    Metformin combined with dipeptidyl peptidase-4 inhibitors or metformin combined with sulfonylureas in patients with type 2 diabetes: A real world analysis of the South Korean national cohort.
    Metabolism. 2018 Mar 9. pii: S0026-0495(18)30081.
    >> Share

  120. REUTRAKUL S, Van Cauter E
    Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes.
    Metabolism. 2018 Mar 3. pii: S0026-0495(18)30063.
    >> Share

    February 2018
  121. CHOI SR, Lim JH, Kim MY, Kim EN, et al
    Adiponectin Receptor Agonist AdipoRon Decreased Ceramide, and Lipotoxicity, and Ameliorated Diabetic Nephropathy.
    Metabolism. 2018 Feb 17. pii: S0026-0495(18)30043.
    >> Share

  122. TIMOTHY GARVEY W, Van Gaal L, Leiter LA, Vijapurkar U, et al
    Effects of Canagliflozin Versus Glimepiride on Adipokines and Inflammatory Biomarkers in Type 2 Diabetes.
    Metabolism. 2018 Feb 13. pii: S0026-0495(18)30041.
    >> Share

  123. LI TC, Li CI, Liu CS, Lin WY, et al
    Development and validation of prediction models for the risks of diabetes-related hospitalization and in-hospital mortality in patients with type 2 diabetes.
    Metabolism. 2018 Feb 13. pii: S0026-0495(18)30042.
    >> Share

  124. KINTIRAKI E, Dipla K, Triantafyllou A, Koletsos N, et al
    Blunted cerebral oxygenation during exercise in women with gestational diabetes mellitus: associations with macrovascular function and cardiovascular risk factors.
    Metabolism. 2018 Feb 1. pii: S0026-0495(18)30015.
    >> Share

    January 2018
  125. HOLINGUE C, Wennberg A, Berger S, Polotsky VY, et al
    Disturbed Sleep and Diabetes: A Potential Nexus of Dementia Risk.
    Metabolism. 2018 Jan 31. pii: S0026-0495(18)30029.
    >> Share

  126. NISHIHAMA K, Yasuma T, Yano Y, D' Alessandro-Gabazza CN, et al
    Anti-apoptotic activity of human matrix Metalloproteinase-2 attenuates diabetes mellitus.
    Metabolism. 2018 Jan 20. pii: S0026-0495(18)30022.
    >> Share

  127. WU R, Liu X, Yin J, Wu H, et al
    IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice.
    Metabolism. 2018 Jan 11. pii: S0026-0495(18)30007.
    >> Share

  128. BROSKEY NT, Obanda DN, Burton JH, Cefalu WT, et al
    Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes.
    Metabolism. 2018 Jan 4. pii: S0026-0495(17)30359.
    >> Share

  129. PASTEL E, Price E, Sjoholm K, McCulloch LJ, et al
    Lysyl oxidase and adipose tissue dysfunction.
    Metabolism. 2018;78:118-127.
    >> Share

    December 2017
  130. SONODA N, Morimoto A, Tatsumi Y, Asayama K, et al
    A prospective study of the impact of diabetes mellitus on restrictive and obstructive lung function impairment: the Saku study.
    Metabolism. 2017 Dec 28. pii: S0026-0495(17)30343.
    >> Share

  131. XIAOYAN Z, Yang W, Wang J, Meng Y, et al
    FAM3 gene family: a promising therapeutical target for NAFLD and type 2 diabetes.
    Metabolism. 2017 Dec 5. pii: S0026-0495(17)30336.
    >> Share

  132. MIZUNO Y, Harada E, Nakagawa H, Morikawa Y, et al
    The diabetic heart utilizes ketone bodies as an energy source.
    Metabolism. 2017;77:65-72.
    >> Share

    November 2017
  133. WU D, Yan ZB, Cheng YG, Zhong MW, et al
    Deactivation of the NLRP3 inflammasome in infiltrating macrophages by duodenal-jejunal bypass surgery mediates improvement of beta cell function in type 2 diabetes.
    Metabolism. 2017 Nov 9. pii: S0026-0495(17)30304.
    >> Share

  134. ZIEGLER D, Strom A, Bonhof G, Puttgen S, et al
    Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed type 1 and type 2 diabetes.
    Metabolism. 2017 Nov 4. pii: S0026-0495(17)30301.
    >> Share

  135. SAHIN-EFE A, Upadhyay J, Ko BJ, Dincer F, et al
    Irisin and Leptin Concentrations in relation to Obesity, and Developing Type 2 Diabetes: a cross sectional and a prospective case-control study nested in the Normative Aging Study.
    Metabolism. 2017 Nov 3. pii: S0026-0495(17)30299.
    >> Share

  136. ITO Y, Hsu MF, Bettaieb A, Koike S, et al
    Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
    Metabolism. 2017;76:56-69.
    >> Share

    October 2017
  137. LI LJ, Tan KH, Aris IM, Man REK, et al
    Retinal Vasculature and 5-Year Metabolic Syndrome among Women with Gestational Diabetes Mellitus.
    Metabolism. 2017 Oct 16. pii: S0026-0495(17)30278.
    >> Share

  138. GALLO M, Muscogiuri G, Felicetti F, Faggiano A, et al
    Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes.
    Metabolism. 2017 Oct 6. pii: S0026-0495(17)30265.
    >> Share

  139. GUELFI KJ, Ong MJ, Li S, Wallman KE, et al
    Maternal circulating adipokine profile and insulin resistance in women at high risk of developing gestational diabetes mellitus.
    Metabolism. 2017;75:54-60.
    >> Share

  140. SONDERGAARD E, Johansen RF, Jensen MD, Nielsen S, et al
    Postprandial VLDL-TG metabolism in type 2 diabetes.
    Metabolism. 2017;75:25-35.
    >> Share

    September 2017
  141. CUI X, You L, Zhu L, Wang X, et al
    Change in circulating microRNA profile of obese children indicates future risk of adult diabetes.
    Metabolism. 2017 Sep 28. pii: S0026-0495(17)30250.
    >> Share

  142. SUVITAIVAL T, Bondia-Pons I, Yetukuri L, Poho P, et al
    Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men.
    Metabolism. 2017 Sep 20. pii: S0026-0495(17)30230.
    >> Share

  143. UPADHYAY J, Polyzos SA, Perakakis N, Thakkar B, et al
    Pharmacotherapy of Type 2 Diabetes: An Update.
    Metabolism. 2017 Sep 8. pii: S0026-0495(17)30216.
    >> Share

    August 2017
  144. WANG H, Song Y, Sun S, Gao L, et al
    The association between immunoglobulin concentrations and prediabetes prevalence in a large Chinese cohort.
    Metabolism. 2017;73:77-84.
    >> Share

    July 2017
  145. THOMAS D, Apovian C
    Macrophage functions in lean and obese adipose tissue.
    Metabolism. 2017;72:120-143.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016